ADC Therapeutics
ADC Therapeutics is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers.
Business Model:
Revenue: $137.9M
Employees: 201-500
Rankings
Industries / Tags:
Detailed ADC Therapeutics Information
Geographic Data
Address: Route de la Corniche 3B
City: Epalinges
State: vaud
Zip: 1066
Country: CH
Financial Info
Stage:
post ipo debt
Raised Last:
$50M
Raised Total:$692M
Social
Metrics
2,174,450Website Global Rank
9,110Website Monthly Traffic
Twitter Followers
Description
ADC Therapeutics is a Switzerland-based biotechnology company that develops proprietary antibody-drug conjugates for the treatment of solid and hematological cancers.
Contact Phone:
Contact Email:
ADC Therapeutics went public on 5/14/2020 on the NYSE
Listed Exchange:
NYSE
IPO Date:
5/14/2020
IPO Valuation:
$1B
Ticker Symbol:
ADCT
IPO Price:
$19/share
Amount Raised:
$233M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
